What's breaking now, across thousands of outlets.
Replimune finally has its eureka moment. After two rejections, public clashing with the previous FDA leaders and a closed-door meeting with the White House, the Massachusetts biotech on Thursday received accelerated approval for its advanced ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.
(MedPage Today) -- The FDA approved the trivalent flu vaccine mRNA-1010 (mFLUSIVA) for use in all adults age 50 years or older, Moderna announced on Wednesday.
The FDA approved Replimune’s treatment for advanced melanoma, dealing the company and patient advocates a big win after a tumultuous saga.
A garda with severe asthma, withdrawn from a work-from-home arrangement and ordered back on the beat during a winter Covid-19 surge in 2022, was discriminated against - but it is too late to recover…
In this edition of the Nautilus Biotechnology “Proteomics and neuroscience” eBook, we’re excited to dive into tau biology, share what researchers are learning about tau and its role in Alzheimer’s…
Discover how the inconspicuous nucleocapsid protein from coronaviruses can trigger hyperinflammation, an effect not typically seen in other viruses.
The surge in jellyfish along the Cantabrian coast has forced swimming bans on several Basque beaches and prompted health authorities to step up advice on what to do if stung.
